These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11843523)

  • 21. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulant management of patients with mechanical prosthetic valves undergoing non-cardiac surgery: indications and unresolved issues.
    Shapira Y; Vaturi M; Sagie A
    J Heart Valve Dis; 2001 May; 10(3):380-7. PubMed ID: 11380104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low intensity anticoagulation therapy after mechanical heart valve replacement].
    Dong L; Shi YK; Tian ZP; Ma JY; Wang X; Yi J
    Zhonghua Wai Ke Za Zhi; 2003 Apr; 41(4):250-2. PubMed ID: 12882664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
    Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
    J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio.
    Azarnoush K; Camilleri L; Aublet-Cuvelier B; Geoffroy E; Dauphin C; Dubray C; De Riberolles C
    J Heart Valve Dis; 2011 Sep; 20(5):518-25. PubMed ID: 22066355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy after mechanical mitral valve replacement.
    Vural KM; Ozatik MA; Uncu H; Emir M; Yurdagök O; Sener E; Tasdemir O
    J Heart Valve Dis; 2003 May; 12(3):370-6. PubMed ID: 12803338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient self-monitoring of prosthetic heart valve function.
    Fritzsche D; Schenk S; Eitz T; Mantas J; Horstkotte D; Koerfer R
    J Heart Valve Dis; 2007 Sep; 16(5):558-66. PubMed ID: 17944129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients.
    Tschol N; Lai DK; Tilley JA; Wong H; Brown GR
    Can J Cardiol; 2003 Nov; 19(12):1413-7. PubMed ID: 14631476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
    Descarries LM; Leduc L; Khairy P; Mercier LA
    J Heart Valve Dis; 2006 Sep; 15(5):679-85. PubMed ID: 17044374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient self-management of oral anticoagulation.
    Fancher TL; White RH
    Curr Hematol Rep; 2004 Sep; 3(5):368-74. PubMed ID: 15341705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-management program improves anticoagulation control and quality of life: a prospective randomized study.
    Soliman Hamad MA; van Eekelen E; van Agt T; van Straten AH
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):265-9. PubMed ID: 19041254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Update of INR-selfmonitoring].
    Völler H; Braun S
    Hamostaseologie; 2008 Oct; 28(4):231-3. PubMed ID: 18836650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.
    Wittkowsky AK; Sekreta CM; Nutescu EA; Ansell J
    Pharmacotherapy; 2005 Feb; 25(2):265-9. PubMed ID: 15767240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
    Meurin P; Tabet JY; Weber H; Renaud N; Ben Driss A
    Circulation; 2006 Jan; 113(4):564-9. PubMed ID: 16449734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.